258 related articles for article (PubMed ID: 35976559)
21. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
[TBL] [Abstract][Full Text] [Related]
22. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
[TBL] [Abstract][Full Text] [Related]
23. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
[TBL] [Abstract][Full Text] [Related]
26. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
27. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
[TBL] [Abstract][Full Text] [Related]
28. Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Rajasekhar M; Simpson JA; Ley B; Edler P; Chu CS; Abreha T; Awab GR; Baird JK; Bancone G; Barber BE; Grigg MJ; Hwang J; Karunajeewa H; Lacerda MVG; Ladeia-Andrade S; Llanos-Cuentas A; Pukrittayakamee S; Rijal KR; Saravu K; Sutanto I; Taylor WRJ; Thriemer K; Watson JA; Guerin PJ; White NJ; Price RN; Commons RJ;
Lancet Infect Dis; 2024 Feb; 24(2):184-195. PubMed ID: 37748497
[TBL] [Abstract][Full Text] [Related]
29. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
30. Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses.
Yilma D; Groves ES; Brito-Sousa JD; Monteiro WM; Chu C; Thriemer K; Commons RJ; Lacerda MVG; Price RN; Douglas NM
Am J Trop Med Hyg; 2023 Oct; 109(4):761-769. PubMed ID: 37604475
[TBL] [Abstract][Full Text] [Related]
31. Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function.
Douglas NM; Piera KA; Rumaseb A; Ley B; Anstey NM; Price RN
Am J Trop Med Hyg; 2023 Jan; 108(1):76-80. PubMed ID: 36509054
[TBL] [Abstract][Full Text] [Related]
32. G6PD deficiency: global distribution, genetic variants and primaquine therapy.
Howes RE; Battle KE; Satyagraha AW; Baird JK; Hay SI
Adv Parasitol; 2013; 81():133-201. PubMed ID: 23384623
[TBL] [Abstract][Full Text] [Related]
33. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
Thriemer K; Poespoprodjo JR; Kenangalem E; Douglas NM; Sugiarto P; Anstey NM; Simpson JA; Price RN
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008838. PubMed ID: 33175835
[TBL] [Abstract][Full Text] [Related]
34. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
[TBL] [Abstract][Full Text] [Related]
35. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rodrigo C; Rajapakse S; Fernando D
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.
Shenkutie TT; Nega D; Hailu A; Kepple D; Witherspoon L; Lo E; Negash MT; Adamu A; Gebremichael SG; Gidey B; Tasew G; Feleke SM; Kebede T
Malar J; 2022 Sep; 21(1):260. PubMed ID: 36076204
[TBL] [Abstract][Full Text] [Related]
37. Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
Kondrashin A; Baranova AM; Ashley EA; Recht J; White NJ; Sergiev VP
Malar J; 2014 Feb; 13():51. PubMed ID: 24502194
[TBL] [Abstract][Full Text] [Related]
38. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
39. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.
Myat-Phone-Kyaw ; Myint-Oo ; Aung-Naing ; Aye-Lwin-Htwe
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):710-3. PubMed ID: 7667719
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the CareStartâ„¢ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]